Iovance Biotherapeutics
IOVA
IOVA
81 hedge funds and large institutions have $361M invested in Iovance Biotherapeutics in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.
Holders
81
Holders Change
-6
Holders Change %
-6.9%
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
5
Increased
31
Reduced
25
Closed
6
Calls
$1.19M
Puts
$139K
Net Calls
+$1.06M
Net Calls Change
+$2.02M
Top Buyers
| 1 |
1
BlackRock
New York
|
$45.2M |
| 2 |
GTC
2
Ghost Tree Capital
New York
|
$8.94M |
| 3 |
3
Goldman Sachs
New York
|
$1.9M |
| 4 |
4
Victory Capital Management
San Antonio,
Texas
|
$18.9M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$3.73M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Creative Planning
Overland Park,
Kansas
| $7K | – | – | – |
|
|
MAM
77
Meeder Asset Management
Dublin,
Ohio
| $4K | +$4K | +490 | New |
|
78
BNP Paribas Financial Markets
Paris,
France
| $3.34K | -$21K | -2,820 | -86% |
|
|
TRCT
79
Tower Research Capital (TRC)
New York
| $1K | -$22.6K | -4,521 | -96% |
|
80
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
MTIP
81
Magee Thomson Investment Partners
San Diego,
California
| $1K | +$1K | +99 | New |
|
82
First Eagle Investment Management
New York
| – | -$1.04M | -150,000 | Closed |
|
83
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$876K | -126,015 | Closed |
|
|
SCA
84
Secor Capital Advisors
New York
| – | -$110K | -15,787 | Closed |
|
85
D.E. Shaw & Co
New York
| – | -$103K | -14,778 | Closed |
|
86
JPMorgan Chase & Co
New York
| – | -$46K | -6,575 | Closed |
|